New cancer clinical trial: Trial of Local Consolidation Therapy (LCT) After Osimertinib for Patients With EGFR Mutant Metastatic Non-Small Cell Lung Cancer (NSCLC)

Published on: January 25, 2018 at 12:00PM
Conditions:   Malignant Neoplasms of Respiratory and Intrathoracic Organs;   Non-small Cell Lung Cancer
Interventions:   Drug: Osimertinib;   Procedure: Local Consolidation Therapy (LCT)
Sponsors:   M.D. Anderson Cancer Center;   National Comprehensive Cancer Network;   AstraZeneca
Recruiting
http://ift.tt/2ncQL16